(S (NP (NNP Melanoma)) (VP (VBZ is) (NP (NP (DT a) (NN type)) (PP (IN of) (NP (JJ skin) (NN cancer))) (PP (IN with) (NP (DT the) (ADJP (ADVP (RBS most) (RB rapidly)) (VBG increasing)) (NN incidence))))) (. .))
(S (NP (NP (JJ Early) (NN detection)) (PP (IN of) (NP (NN melanoma))) (VP (VBG using) (NP (NN dermoscopy) (NNS images)))) (VP (ADVP (RB significantly)) (VBZ increases) (NP (NP (NNS patients) (POS â€º)) (JJ survival) (NN rate))) (. .))
(S (ADVP (RB However)) (, ,) (S (VP (ADVP (RB accurately)) (VBG classifying) (NP (JJ skin) (NNS lesions)) (PP (IN by) (NP (NN eye))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (DT the) (JJ early) (NN stage)) (PP (IN of) (NP (NN melanoma))))) (, ,))) (VP (VBZ is) (ADJP (RB extremely) (VBG challenging)) (PP (IN for) (NP (DT the) (NNS dermatologists)))) (. .))
(S (ADVP (NNP Hence)) (, ,) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (JJ reliable) (NNS biomarkers)))) (VP (MD will) (VP (VB be) (ADJP (JJ meaningful) (PP (IN for) (NP (JJ melanoma) (NN diagnosis)))))) (. .))
(S (NP (JJ Recent) (NNS years)) (, ,) (NP (NP (DT the) (NN value)) (PP (IN of) (NP (ADJP (JJ deep) (NN learning) (VBD empowered)) (JJ computer-assisted) (NN diagnose)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (PP (IN in) (NP (ADJP (JJ biomedical) (NN imaging) (VBN based)) (NN decision) (NN making)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (JJ much) (NN research)) (VP (VBZ focuses) (PP (IN on) (S (VP (VP (VBG improving) (NP (NN disease) (NN detection) (NN accuracy))) (CC but) (RB not) (VP (VBG exploring) (NP (NP (DT the) (NN evidence)) (PP (IN of) (NP (NN pathology))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN method)) (SBAR (S (VP (TO to) (VP (VB interpret) (NP (DT the) (JJ deep) (NN learning) (NN classification) (NNS findings)))))))) (. .))
(S (ADVP (RB Firstly)) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT an) (JJ accurate) (JJ neural) (NN network) (NN architecture)) (SBAR (S (VP (TO to) (VP (VB classify) (NP (JJ skin) (NNS lesions)))))))) (. .))
(S (ADVP (RB Secondly)) (, ,) (NP (PRP we)) (VP (VBP utilize) (NP (NP (DT a) (NN prediction) (NN difference) (NN analysis) (NN method)) (SBAR (WHNP (WDT that)) (S (VP (VBZ examines) (NP (NP (DT each) (NN patch)) (PP (IN on) (NP (DT the) (NN image)))) (PP (IN through) (NP (JJ patch-wised) (NN corrupting))) (S (VP (TO to) (VP (VB detect) (NP (DT the) (NNS biomarkers)))))))))) (. .))
(S (ADVP (RB Lastly)) (, ,) (NP (PRP we)) (VP (VBP validate) (SBAR (IN that) (S (NP (PRP$ our) (NN biomarker) (NNS findings)) (VP (VBP are) (VP (VBG corresponding) (PP (TO to) (NP (NP (DT the) (NNS patterns)) (PP (IN in) (NP (DT the) (NN literature)))))))))) (. .))
(S (NP (DT The) (NNS findings)) (VP (MD can) (VP (VB be) (ADJP (JJ significant) (CC and) (JJ useful) (S (VP (TO to) (VP (VB guide) (NP (JJ clinical) (NN diagnosis)))))))) (. .))
